• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉痉挛:危险因素、病理生理机制及新型诊断方法

Coronary Artery Spasm: Risk Factors, Pathophysiological Mechanisms and Novel Diagnostic Approaches.

作者信息

Lin Zijie, Lin Xinyi, Zhao Xin, Xu Chenchao, Yu Bokang, Shen Yiwen, Li Liliang

机构信息

Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University, 200032 Shanghai, China.

Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 200032 Shanghai, China.

出版信息

Rev Cardiovasc Med. 2022 May 16;23(5):175. doi: 10.31083/j.rcm2305175. eCollection 2022 May.

DOI:10.31083/j.rcm2305175
PMID:39077604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11273663/
Abstract

Coronary artery spasm (CAS) is a transient reversible subtotal or complete occlusion induced by coronary hypercontraction and the critical cause of myocardial ischaemia with non-obstructive coronary arteries. During the past decades, our knowledge of the risk factors and pathophysiological mechanisms of CAS have been increasingly progressed, and various diagnostic approaches, including imaging technologies and novel biomarkers, have been proposed to serve well to diagnose CAS clinically. This review aims to summarize these research progresses on the risk factors of CAS and introduce current knowledge about the mechanisms accounting for CAS, including endothelial dysfunction, vascular smooth muscle cell hyperreactivity, and adventitial and perivascular adipose tissue inflammation. We also gathered the recently evolved diagnostic approaches and analyzed their advantages/disadvantages, in purpose of enhancing the diagnostic yield on the basis of ensuring accuracy.

摘要

冠状动脉痉挛(CAS)是一种由冠状动脉过度收缩引起的短暂可逆性次全或完全闭塞,是非阻塞性冠状动脉心肌缺血的关键原因。在过去几十年中,我们对CAS的危险因素和病理生理机制的认识不断进步,并且已经提出了包括成像技术和新型生物标志物在内的各种诊断方法,以很好地用于临床诊断CAS。这篇综述旨在总结CAS危险因素的这些研究进展,并介绍目前关于CAS发生机制的知识,包括内皮功能障碍、血管平滑肌细胞高反应性以及外膜和血管周围脂肪组织炎症。我们还收集了最近发展的诊断方法并分析了它们的优缺点,目的是在确保准确性的基础上提高诊断率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d27d/11273663/c737acda1014/2153-8174-23-5-175-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d27d/11273663/ce98d3ff9941/2153-8174-23-5-175-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d27d/11273663/3fcf8f339f42/2153-8174-23-5-175-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d27d/11273663/c737acda1014/2153-8174-23-5-175-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d27d/11273663/ce98d3ff9941/2153-8174-23-5-175-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d27d/11273663/3fcf8f339f42/2153-8174-23-5-175-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d27d/11273663/c737acda1014/2153-8174-23-5-175-g3.jpg

相似文献

1
Coronary Artery Spasm: Risk Factors, Pathophysiological Mechanisms and Novel Diagnostic Approaches.冠状动脉痉挛:危险因素、病理生理机制及新型诊断方法
Rev Cardiovasc Med. 2022 May 16;23(5):175. doi: 10.31083/j.rcm2305175. eCollection 2022 May.
2
Coronary Artery Spasm: The Interplay Between Endothelial Dysfunction and Vascular Smooth Muscle Cell Hyperreactivity.冠状动脉痉挛:内皮功能障碍与血管平滑肌细胞高反应性之间的相互作用
Eur Cardiol. 2020 Apr 6;15:e12. doi: 10.15420/ecr.2019.20. eCollection 2020 Feb.
3
Evaluation of Therapeutic Agents Targeting the Pathogenesis of Coronary Artery Spasm: A Mini Review.针对冠状动脉痉挛发病机制的治疗药物评估:一篇综述
Curr Vasc Pharmacol. 2021;19(4):347-358. doi: 10.2174/1570161118666200603131119.
4
Cellular Mechanisms of Coronary Artery Spasm.冠状动脉痉挛的细胞机制
Biomedicines. 2022 Sep 21;10(10):2349. doi: 10.3390/biomedicines10102349.
5
Mechanisms of Coronary Artery Spasm.冠状动脉痉挛的机制
Eur Cardiol. 2023 May 30;18:e39. doi: 10.15420/ecr.2022.55. eCollection 2023.
6
Coronary Artery Spasm, Coronary Reactivity, and Their Psychological Context.冠状动脉痉挛、冠状动脉反应性及其心理背景。
Psychosom Med. 2019 Apr;81(3):233-236. doi: 10.1097/PSY.0000000000000682.
7
Vasospastic Angina: A Contemporary Review of its Pathophysiology, Diagnosis and Management.血管痉挛性心绞痛:其病理生理学、诊断与管理的当代综述
Heart Int. 2022 Jul 26;16(2):99-104. doi: 10.17925/HI.2022.16.2.99. eCollection 2022.
8
[Research Progress and Forensic Application on the Pathogenesis of Coronary Artery Spasm].[冠状动脉痉挛发病机制的研究进展及法医学应用]
Fa Yi Xue Za Zhi. 2018 Feb;34(1):60-66. doi: 10.3969/j.issn.1004-5619.2018.01.012. Epub 2018 Feb 25.
9
Vasospastic angina: a review on diagnostic approach and management.血管痉挛性心绞痛:诊断方法和治疗的综述。
Ther Adv Cardiovasc Dis. 2024 Jan-Dec;18:17539447241230400. doi: 10.1177/17539447241230400.
10
Phosphorylated CPI-17 and MLC2 as Biomarkers of Coronary Artery Spasm-Induced Sudden Cardiac Death.磷酸化的CPI-17和MLC2作为冠状动脉痉挛诱发心源性猝死的生物标志物。
Int J Mol Sci. 2024 Mar 3;25(5):2941. doi: 10.3390/ijms25052941.

引用本文的文献

1
Coronary Artery Spasm: From Physiopathology to Diagnosis.冠状动脉痉挛:从病理生理学到诊断
Life (Basel). 2025 Apr 3;15(4):597. doi: 10.3390/life15040597.
2
Myocardial infarction with non-obstructive coronary artery caused by coronary artery spasm and an increase in serum homocysteine: a case report.冠状动脉痉挛和血清同型半胱氨酸升高所致非阻塞性冠状动脉心肌梗死:一例报告
Eur Heart J Case Rep. 2025 Mar 6;9(3):ytaf118. doi: 10.1093/ehjcr/ytaf118. eCollection 2025 Mar.
3
The correlation between cumulative cigarette consumption and infarction-related coronary spasm in patients with ST-segment elevation acute myocardial infarction across different age groups.

本文引用的文献

1
Pathophysiology and Diagnosis of Coronary Functional Abnormalities.冠状动脉功能异常的病理生理学与诊断
Eur Cardiol. 2021 Sep 3;16:e30. doi: 10.15420/ecr.2021.23. eCollection 2021 Feb.
2
Segmental Coronary Vasospasm Mimicking ST-Elevation Myocardial Infarction in an Incidentally COVID-Positive Patient.偶然 COVID 阳性患者的节段性冠状动脉痉挛酷似 ST 段抬高型心肌梗死。
S D Med. 2021 Jun;74(6):248-249.
3
Coronary artery lumen complexity as a new marker for refractory symptoms in patients with vasospastic angina.冠状动脉管腔复杂性作为血管痉挛性心绞痛患者难治性症状的新标志物。
不同年龄组ST段抬高型急性心肌梗死患者累积吸烟量与梗死相关冠状动脉痉挛之间的相关性。
Sci Rep. 2025 Jan 2;15(1):253. doi: 10.1038/s41598-024-84125-5.
4
Drug-Induced Myocardial Infarction: A Review of Pharmacological Triggers and Pathophysiological Mechanisms.药物性心肌梗死:药理触发因素与病理生理机制综述
J Cardiovasc Dev Dis. 2024 Dec 18;11(12):406. doi: 10.3390/jcdd11120406.
5
Cellular Characteristics and Protein Signatures of Human Adipose Tissues from Donors With or Without Advanced Coronary Artery Disease.患有或未患有晚期冠状动脉疾病的供体的人体脂肪组织的细胞特征和蛋白质特征
Biomedicines. 2024 Oct 25;12(11):2453. doi: 10.3390/biomedicines12112453.
6
Paroxysmal Atrial Fibrillation as the First Presentation of Coronary Artery Spasm.阵发性心房颤动作为冠状动脉痉挛的首发表现
Cureus. 2024 Oct 10;16(10):e71186. doi: 10.7759/cureus.71186. eCollection 2024 Oct.
7
Phosphorylated CPI-17 and MLC2 as Biomarkers of Coronary Artery Spasm-Induced Sudden Cardiac Death.磷酸化的CPI-17和MLC2作为冠状动脉痉挛诱发心源性猝死的生物标志物。
Int J Mol Sci. 2024 Mar 3;25(5):2941. doi: 10.3390/ijms25052941.
8
Frequency and Clinical Impact of Family History of Coronary Artery Disease in Patients with Vasospastic Angina.变异性心绞痛患者冠状动脉疾病家族史的频率及临床影响
J Cardiovasc Dev Dis. 2023 Jun 8;10(6):249. doi: 10.3390/jcdd10060249.
9
Serum SELENBP1 and VCL Are Effective Biomarkers for Clinical and Forensic Diagnosis of Coronary Artery Spasm.血清 SELENBP1 和 VCL 是冠状动脉痉挛临床和法医诊断的有效生物标志物。
Int J Mol Sci. 2022 Oct 31;23(21):13266. doi: 10.3390/ijms232113266.
Sci Rep. 2021 Jan 8;11(1):13. doi: 10.1038/s41598-020-79669-1.
4
Imaging and Pathology of Eosinophilic Coronary Periarteritis.嗜酸性冠状动脉周围炎的影像学与病理学
JACC Cardiovasc Interv. 2020 Aug 24;13(16):e151-e154. doi: 10.1016/j.jcin.2020.05.014. Epub 2020 Jul 29.
5
Severe coronary spasm in a COVID-19 patient.COVID-19 患者发生严重冠状动脉痉挛。
Catheter Cardiovasc Interv. 2021 Apr 1;97(5):E670-E672. doi: 10.1002/ccd.29056. Epub 2020 Aug 1.
6
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.一份由欧洲心脏病学会冠状动脉病理生理学与微循环工作组合作完成,并经冠状动脉血管舒缩障碍国际研究组认可的关于非阻塞性冠状动脉缺血的欧洲经皮心血管介入学会专家共识文件。
Eur Heart J. 2020 Oct 1;41(37):3504-3520. doi: 10.1093/eurheartj/ehaa503.
7
Coronary Artery Spasm: New Insights.冠状动脉痉挛:新的认识。
J Interv Cardiol. 2020 May 14;2020:5894586. doi: 10.1155/2020/5894586. eCollection 2020.
8
Safety assessment and results of coronary spasm provocation testing in patients with myocardial infarction with unobstructed coronary arteries compared to patients with stable angina and unobstructed coronary arteries.与冠状动脉正常的稳定型心绞痛患者相比,冠状动脉正常的心肌梗死患者进行冠状动脉痉挛激发试验的安全性评估及结果
Eur Heart J Acute Cardiovasc Care. 2021 May 25;10(4):380–387. doi: 10.1177/2048872620932422. Epub 2020 Jun 8.
9
Diagnostic and Prognostic Value of Ergonovine Echocardiography for Noninvasive Diagnosis of Coronary Vasospasm.麦角新碱超声心动图在非侵入性诊断冠状动脉痉挛中的诊断和预后价值。
JACC Cardiovasc Imaging. 2020 Sep;13(9):1875-1887. doi: 10.1016/j.jcmg.2020.03.008. Epub 2020 May 13.
10
Coronary Artery Spasm: The Interplay Between Endothelial Dysfunction and Vascular Smooth Muscle Cell Hyperreactivity.冠状动脉痉挛:内皮功能障碍与血管平滑肌细胞高反应性之间的相互作用
Eur Cardiol. 2020 Apr 6;15:e12. doi: 10.15420/ecr.2019.20. eCollection 2020 Feb.